We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -3.23% | 1.50 | 1.40 | 1.60 | 1.50 | 1.50 | 1.50 | 242,798 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.29 | 2.03M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/6/2020 14:50 | I think it's been evident a LOT of stuff going on in background Management seemingly increasingly confident (but they are conservative so always seek to under-promise and over-deliver) They've known since late 2019 they were reeling in a Big Pharma If it isn't GSK/AZN/Pfizer (my top 3 guesses) then we've still got one of those to look forward to ! Basically it's Domino theory / Snowball effect. Merck KGaA way ahead of the curve. A real bleeding edge player. Next Pharma will be a Leading Edge payer. We are maybe 2-3 years from going seriously Mass Market where EVERY BIG PHARMA will need to get on board. Maybe even FDA / MHRA etc will start to REQUIRE Companies to submit In-Silico Clinical Studies alongside normal in-vitro/in-vivo studies ? Seriously revolutionary stuff. Glad Schrodinger is listed now so people can see this is the AGE of COMPUTATIONAL BIOLOGY | the stigologist | |
05/6/2020 14:09 | Another tick up 😉 | stoop | |
05/6/2020 14:01 | In this regard, in the last two working days, the Company has received a strong indication that a significant contract is likely to be signed with a new large pharmaceutical client, with which it has been in discussions since late 2019. While is it still possible that the potential new client could withdraw, it is the Directors' opinion that this is unlikely. | stoop | |
05/6/2020 13:58 | All in the placing RNS. Company have put it in black and white for investors. As soon as I saw the placing was sticky it was an easy decision to take a decent stake ahead of news. | aimbagger | |
05/6/2020 13:54 | How do you know? Any source? Thanks | drnash79 | |
05/6/2020 13:44 | TR1 should land imminently ahead of contract news | aimbagger | |
05/6/2020 13:27 | News due soon | stoop | |
04/6/2020 18:59 | Lovely chart developing here to go with Fundamentals and Newsflow catalysts | the stigologist | |
04/6/2020 17:49 | The Stig…..fantast | ant15 | |
04/6/2020 16:11 | The company has been very well supported recently by individuals and ii’s. Zahid Ali increased his holding to 5.04% on 15th May and in the placing RNS the company stated that a new (its first) institutional fund took part. TR1 due over the next couple of days. The key upcoming catalyst is the significant contract due with a new large pharma as mentioned in the placing RNS. The last time they announced a significant contract with Merck the share price went nuts. 30 bagged. Not expecting the same but RvR is very good from this level. | aimbagger | |
04/6/2020 15:40 | 4.642 are buys | herb clark | |
04/6/2020 10:14 | Think this is under the radar. Investors chasing Covid-19 vaccine and testing kit shares. Some stocks over-inflated, also not all will be successful. When we have contract news here,hopefully soon, this will explode. IMHO | mam fach | |
04/6/2020 09:58 | Looking great this morning ahead of contract news. Hopefully we can break 5p before released. | aimbagger | |
04/6/2020 09:58 | Did a thread on possible contenders to be the 'Large Pharma' client 4 of Physiomics employees/chair/ceo have AstraZeneca and GSK/Glaxo links PYC could also possibly gain access to Pfizer and GSK thru Merck KGaA relationship | the stigologist | |
04/6/2020 08:41 | Could lol wait till significant contract news! | zen12 | |
04/6/2020 08:37 | Could test 5p today | stoop | |
04/6/2020 08:14 | If companies like AVCT can raise £50m at drop of a hat... How much money is coming the way of 'picks and shovel' suppliers like PYC ? | the stigologist | |
03/6/2020 22:41 | Pyc have a nack of announcing big contracts with UNDSICLOSED FEE. Shttt share managed by Jim the cunning Jc only.hope | spacedust | |
03/6/2020 19:41 | aim bagger ramping scum here nowramps fly out from his lying mouth lost his shirt on braveheart now gambling herei see he left brave heart thread without a goodbye but I been told he informe his discord sheeple followers | backtogo | |
03/6/2020 18:36 | Chart looking pretty good here medium term. Constructive off Golden Cross, 50 day MA and above Placing level | the stigologist | |
03/6/2020 17:50 | Not when they raised They only announced Big Company tie up AFTER placing PYC given us heads up of news incoming | the stigologist | |
03/6/2020 17:39 | Yes but why would we rise 500% on a placing? They had covid test links | markth126 | |
03/6/2020 17:26 | AVCT rose 500%+ within one month of their April placing RNS | the stigologist | |
03/6/2020 16:56 | Yep it's certainly in imminent territory now.RNS stated '... and the Directors believe that this has been further strengthened since that announcement.In this regard, in the last two working days, the Company has received a strong indication that a significant contract is likely to be signed with a new large pharmaceutical client, with which it has been in discussions since late 2019. While is it still possible that the potential new client could withdraw, it is the Directors' opinion that this is unlikely. Should the contract be signed, the work is expected to take two of our technical staff around five months to complete.' | zen12 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions